| 11261189 |
Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins B (CTSB), L (CTSL) and D (CTSD) related diseases |
Firas Bassissi, Sonia Brun, Jérôme Courcambeck, Madani Rachid |
2022-03-01 |
| 10722505 |
Substituted 2,4 diamino-quinoline as new anticancer agents |
Firas Bassissi, Antoine Beret, Sonia Brun, Jérôme Courcambeck, Clarisse Dubray +1 more |
2020-07-28 |
| 10577362 |
Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases |
Sonia Brun, Antoine Beret, Firas Bassissi, Jérôme Courcambeck |
2020-03-03 |
| 10179770 |
Quinolines derivatives as novel anticancer agents |
Jérôme Courcambeck, Firas Bassissi, Sonia Brun, Gregory Nicolas, Antoine Beret +3 more |
2019-01-15 |
| 8987302 |
Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent |
— |
2015-03-24 |
| 8912141 |
Treatment of hepatitis C virus |
— |
2014-12-16 |
| 8729014 |
Specific HCV NS3 protease inhibitors |
Jérôme Courcambeck, Mourad Bouzidi, Steven J. Coats, Richard Anthony Whitaker |
2014-05-20 |
| 8575195 |
Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent |
— |
2013-11-05 |